$ALCO
ALICO, INC.

2023 Q1 Form 10-Q Financial Statement

#000095017023001826 Filed on February 06, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4
Revenue $21.29M $10.59M
YoY Change -57.1% -30.96%
Cost Of Revenue $27.62M $14.39M
YoY Change -39.48% 6.38%
Gross Profit -$6.328M -$3.801M
YoY Change -258.24% -309.88%
Gross Profit Margin -29.72% -35.9%
Selling, General & Admin $2.667M $2.509M
YoY Change 5.08% -2.9%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.897M $3.950M
YoY Change 1.7% 2.97%
% of Gross Profit
Operating Expenses $2.667M $2.509M
YoY Change 5.08% -2.9%
Operating Profit -$8.995M -$6.310M
YoY Change -715.67% 716.3%
Interest Expense -$1.274M -$1.148M
YoY Change 46.44% 27.41%
% of Operating Profit
Other Income/Expense, Net $330.0K $2.041M
YoY Change 32900.0% -72.98%
Pretax Income -$8.665M -$4.269M
YoY Change -131.86% -162.96%
Income Tax -$534.0K -$1.083M
% Of Pretax Income
Net Earnings -$7.787M -$3.150M
YoY Change -137.61% -131.09%
Net Earnings / Revenue -36.57% -29.75%
Basic Earnings Per Share -$1.02 -$0.41
Diluted Earnings Per Share -$1.02 -$0.41
COMMON SHARES
Basic Shares Outstanding 7.599M 7.593M
Diluted Shares Outstanding 7.599K 7.593M

Balance Sheet

Concept 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $148.0K $269.0K
YoY Change -99.37% 289.86%
Cash & Equivalents $148.0K $269.0K
Short-Term Investments
Other Short-Term Assets $1.593M $1.720M
YoY Change 17.48% -14.09%
Inventory $23.41M $29.00M
Prepaid Expenses
Receivables $8.970M $4.369M
Other Receivables $2.855M $2.199M
Total Short-Term Assets $36.97M $37.56M
YoY Change -47.62% -35.89%
LONG-TERM ASSETS
Property, Plant & Equipment $369.1M $370.1M
YoY Change -1.27% -0.82%
Goodwill $2.246M $2.246M
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.241M $3.094M
YoY Change -47.9% 6.76%
Total Long-Term Assets $374.6M $375.4M
YoY Change -2.02% -0.76%
TOTAL ASSETS
Total Short-Term Assets $36.97M $37.56M
Total Long-Term Assets $374.6M $375.4M
Total Assets $411.6M $413.0M
YoY Change -9.13% -5.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.017M $2.951M
YoY Change 5.74% 6.15%
Accrued Expenses $3.785M $3.306M
YoY Change -52.6% -58.91%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.629M $3.035M
YoY Change -61.98% -29.17%
Total Short-Term Liabilities $14.31M $10.23M
YoY Change -41.66% -35.56%
LONG-TERM LIABILITIES
Long-Term Debt $124.7M $121.9M
YoY Change 4.01% -6.42%
Other Long-Term Liabilities $300.0K $341.0K
YoY Change -52.98% -139.61%
Total Long-Term Liabilities $300.0K $341.0K
YoY Change -52.98% -99.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.31M $10.23M
Total Long-Term Liabilities $300.0K $341.0K
Total Liabilities $174.2M $167.4M
YoY Change -3.92% -10.86%
SHAREHOLDERS EQUITY
Retained Earnings $231.8M $240.0M
YoY Change -13.17%
Common Stock $28.40M $28.36M
YoY Change 0.08%
Preferred Stock
YoY Change
Treasury Stock (at cost) $27.62M $27.80M
YoY Change -4.86% -5.43%
Treasury Stock Shares $816.7K $823.2K
Shareholders Equity $232.6M $240.5M
YoY Change
Total Liabilities & Shareholders Equity $411.6M $413.0M
YoY Change -9.13% -5.47%

Cashflow Statement

Concept 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$7.787M -$3.150M
YoY Change -137.61% -131.09%
Depreciation, Depletion And Amortization $3.897M $3.950M
YoY Change 1.7% 2.97%
Cash From Operating Activities $2.555M -$9.665M
YoY Change -86.12% 0.59%
INVESTING ACTIVITIES
Capital Expenditures $4.691M $3.453M
YoY Change -176.48% -17.65%
Acquisitions
YoY Change
Other Investing Activities $1.076M $3.258M
YoY Change -96.16% -61.53%
Cash From Investing Activities -$3.615M -$496.0K
YoY Change -116.49% -112.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 939.0K 9.565M
YoY Change -106.6% 102.99%
NET CHANGE
Cash From Operating Activities 2.555M -9.665M
Cash From Investing Activities -3.615M -496.0K
Cash From Financing Activities 939.0K 9.565M
Net Change In Cash -121.0K -596.0K
YoY Change -100.46% -27.05%
FREE CASH FLOW
Cash From Operating Activities $2.555M -$9.665M
Capital Expenditures $4.691M $3.453M
Free Cash Flow -$2.136M -$13.12M
YoY Change -108.7% -4.95%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 dei Entity Central Index Key
EntityCentralIndexKey
0000003545
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Ratio Of Indebtedness To Net Capital1
RatioOfIndebtednessToNetCapital1
0.625
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2022Q4 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 dei Document Type
DocumentType
10-Q
CY2022Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q4 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q4 dei Entity File Number
EntityFileNumber
0-261
CY2022Q4 dei Entity Registrant Name
EntityRegistrantName
ALICO, INC.
CY2022Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2022Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
59-0906081
CY2022Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
10070 Daniels Interstate Court
CY2022Q4 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 200
CY2022Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Fort Myers
CY2022Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33913
CY2022Q4 dei City Area Code
CityAreaCode
239
CY2022Q4 dei Local Phone Number
LocalPhoneNumber
226-2000
CY2022Q4 dei Security12b Title
Security12bTitle
Common Stock
CY2022Q4 dei Trading Symbol
TradingSymbol
ALCO
CY2022Q4 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q4 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2022Q4 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q4 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7599492
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
269000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
865000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4369000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
324000
CY2022Q4 us-gaap Inventory Net
InventoryNet
28998000
CY2022Q3 us-gaap Inventory Net
InventoryNet
27682000
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2199000
CY2022Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1116000
CY2022Q4 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
174000
CY2022Q3 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
205000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1546000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1424000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
37555000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
31616000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
370095000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
372479000
CY2022Q4 us-gaap Goodwill
Goodwill
2246000
CY2022Q3 us-gaap Goodwill
Goodwill
2246000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3094000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3094000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2914000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2914000
CY2022Q4 us-gaap Assets
Assets
412990000
CY2022Q3 us-gaap Assets
Assets
409255000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2951000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3366000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3306000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3306000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9062000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3035000
CY2022Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3035000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
933000
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1062000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10225000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10225000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
16525000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
16525000
CY2022Q4 alco Other Longterm Debt Gross Noncurrent
OtherLongtermDebtGrossNoncurrent
102902000
CY2022Q4 alco Other Longterm Debt Gross Noncurrent
OtherLongtermDebtGrossNoncurrent
102902000
CY2022Q3 alco Other Longterm Debt Gross Noncurrent
OtherLongtermDebtGrossNoncurrent
103661000
CY2022Q3 alco Other Longterm Debt Gross Noncurrent
OtherLongtermDebtGrossNoncurrent
103661000
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
716000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
716000
CY2022Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
748000
CY2022Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
102186000
CY2022Q3 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
102913000
CY2022Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
19045000
CY2022Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
4928000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
35589000
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
35589000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
341000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
435000
CY2022Q4 us-gaap Liabilities
Liabilities
167386000
CY2022Q3 us-gaap Liabilities
Liabilities
160390000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8416145
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8416145
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7592937
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
19784000
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
823208
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
239960000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
243490000
CY2022Q3 us-gaap Minority Interest
MinorityInterest
5123000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
245604000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
248865000
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10588000
CY2021Q4 us-gaap Cost Of Revenue
CostOfRevenue
13526000
CY2022Q4 us-gaap Gross Profit
GrossProfit
-3801000
CY2021Q4 us-gaap Gross Profit
GrossProfit
1811000
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2509000
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2584000
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-6310000
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-773000
CY2022Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
1148000
CY2021Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
901000
CY2022Q4 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
3189000
CY2021Q4 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
8445000
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9000
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2041000
CY2022Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
748000
CY2022Q4 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
102186000
CY2022Q3 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
102913000
CY2022Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
19045000
CY2022Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
4928000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
35589000
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
35589000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
341000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
435000
CY2022Q4 us-gaap Liabilities
Liabilities
167386000
CY2022Q3 us-gaap Liabilities
Liabilities
160390000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8416145
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8416145
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7592937
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7586995
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
8416000
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
8416000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
19943000
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
19784000
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
823208
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
829150
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
27802000
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
27948000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
239960000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
243490000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
240517000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
243742000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
5087000
CY2022Q3 us-gaap Minority Interest
MinorityInterest
5123000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
245604000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
248865000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
412990000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
409255000
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10588000
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15337000
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
14389000
CY2021Q4 us-gaap Cost Of Revenue
CostOfRevenue
13526000
CY2022Q4 us-gaap Gross Profit
GrossProfit
-3801000
CY2021Q4 us-gaap Gross Profit
GrossProfit
1811000
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2509000
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2509000
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2584000
CY2022Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
1148000
CY2021Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
901000
CY2021Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
901000
CY2022Q4 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
3189000
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4269000
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4269000
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1083000
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3300000
CY2022Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-36000
CY2021Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-51000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-3150000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
10131000
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7593000
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7593000
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7535000
CY2022Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05
CY2022Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05
CY2021Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
248865000
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-3186000
CY2022Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05
CY2022Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05
CY2022Q4 us-gaap Dividends
Dividends
380000
CY2022Q4 us-gaap Dividends
Dividends
380000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
245604000
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
250117000
CY2021Q4 us-gaap Profit Loss
ProfitLoss
10080000
CY2021Q4 us-gaap Profit Loss
ProfitLoss
10080000
CY2021Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
CY2021Q4 us-gaap Dividends
Dividends
3770000
CY2021Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
170000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
256972000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
256972000
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-3186000
CY2021Q4 us-gaap Profit Loss
ProfitLoss
10080000
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3950000
CY2021Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3836000
CY2022Q4 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
36000
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3950000
CY2021Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3836000
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7553000
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4269000
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6780000
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1083000
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3300000
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-3186000
CY2021Q4 us-gaap Profit Loss
ProfitLoss
10080000
CY2022Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-36000
CY2022Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-36000
CY2021Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-51000
CY2021Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-51000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-3150000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-3150000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
10131000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
10131000
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.34
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.34
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7593000
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7535000
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7535000
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7593000
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7593000
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7542000
CY2022Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05
CY2021Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
248865000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
248865000
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-3186000
CY2022Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05
CY2022Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05
CY2021Q4 us-gaap Profit Loss
ProfitLoss
10080000
CY2021Q4 us-gaap Profit Loss
ProfitLoss
10080000
CY2021Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.50
CY2021Q4 us-gaap Dividends
Dividends
3770000
CY2021Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
170000
CY2021Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
170000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
256972000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
256972000
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-3186000
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-3186000
CY2021Q4 us-gaap Profit Loss
ProfitLoss
10080000
CY2021Q4 us-gaap Profit Loss
ProfitLoss
10080000
CY2022Q4 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
36000
CY2021Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3836000
CY2022Q4 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
36000
CY2021Q4 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
43000
CY2022Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
3189000
CY2021Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
8445000
CY2022Q4 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
1915000
CY2021Q4 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
137000
CY2021Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4876000
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
305000
CY2021Q4 us-gaap Share Based Compensation
ShareBasedCompensation
375000
CY2022Q4 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
8000
CY2022Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4045000
CY2021Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2796000
CY2022Q4 alco Increase Decreasein Prepaid Guaranteed Payments
IncreaseDecreaseinPrepaidGuaranteedPayments
-122000
CY2021Q4 alco Increase Decreasein Prepaid Guaranteed Payments
IncreaseDecreaseinPrepaidGuaranteedPayments
-418000
CY2021Q4 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1576000
CY2022Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-108000
CY2021Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-117000
CY2022Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2822000
CY2021Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6328000
CY2022Q4 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-224000
CY2021Q4 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-336000
CY2021Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4193000
CY2022Q4 alco Payment For Purchases Of Citrus Groves
PaymentForPurchasesOfCitrusGroves
29000
CY2021Q4 alco Payment For Purchases Of Citrus Groves
PaymentForPurchasesOfCitrusGroves
136000
CY2022Q4 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3287000
CY2021Q4 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
8604000
CY2022Q4 alco Payments For Proceeds From Deposits On Purchase Of Productive Assets
PaymentsForProceedsFromDepositsOnPurchaseOfProductiveAssets
301000
CY2021Q4 alco Payments For Proceeds From Deposits On Purchase Of Productive Assets
PaymentsForProceedsFromDepositsOnPurchaseOfProductiveAssets
196000
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-496000
CY2021Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4079000
CY2021Q4 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
16319000
CY2022Q4 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
23019000
CY2021Q4 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
25696000
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9565000
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4712000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-817000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
269000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
69000
CY2022Q4 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9665000
CY2021Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9608000
CY2020 alco Proceeds From Federal Relief Grants
ProceedsFromFederalReliefGrants
4629000
CY2022Q4 alco Proceeds From Federal Relief Grants
ProceedsFromFederalReliefGrants
1300000
CY2021Q4 us-gaap Debt Related Commitment Fees And Debt Issuance Costs
DebtRelatedCommitmentFeesAndDebtIssuanceCosts
43000
CY2022Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
3189000
CY2021Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
8445000
CY2021Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4876000
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
305000
CY2022Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4045000
CY2021Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2796000
CY2022Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1316000
CY2021Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2573000
CY2022Q4 alco Increase Decreasein Prepaid Guaranteed Payments
IncreaseDecreaseinPrepaidGuaranteedPayments
-122000
CY2021Q4 alco Increase Decreasein Prepaid Guaranteed Payments
IncreaseDecreaseinPrepaidGuaranteedPayments
-418000
CY2022Q4 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
1083000
CY2021Q4 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1576000
CY2022Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-108000
CY2021Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-117000
CY2022Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2822000
CY2021Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6328000
CY2022Q4 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-224000
CY2021Q4 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-336000
CY2022Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3453000
CY2021Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4193000
CY2022Q4 alco Payment For Purchases Of Citrus Groves
PaymentForPurchasesOfCitrusGroves
29000
CY2021Q4 alco Payment For Purchases Of Citrus Groves
PaymentForPurchasesOfCitrusGroves
136000
CY2021Q4 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
8604000
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-496000
CY2021Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4079000
CY2022Q4 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
8902000
CY2021Q4 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
25696000
CY2022Q4 us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
759000
CY2021Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
170000
CY2022Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3793000
CY2021Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3763000
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9565000
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4712000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-596000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-817000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
865000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
69000
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10588000
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15337000
CY2022Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
3189000
CY2021Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
8445000
CY2022Q4 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
1915000
CY2021Q4 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
137000
CY2021Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4876000
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
305000
CY2021Q4 us-gaap Share Based Compensation
ShareBasedCompensation
375000
CY2022Q4 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
8000
CY2022Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4045000
CY2021Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2796000
CY2021Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2573000
CY2022Q4 alco Increase Decreasein Prepaid Guaranteed Payments
IncreaseDecreaseinPrepaidGuaranteedPayments
-122000
CY2021Q4 alco Increase Decreasein Prepaid Guaranteed Payments
IncreaseDecreaseinPrepaidGuaranteedPayments
-418000
CY2022Q4 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
1083000
CY2021Q4 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1576000
CY2022Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-108000
CY2021Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-117000
CY2022Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2822000
CY2021Q4 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-336000
CY2022Q4 alco Payment For Purchases Of Citrus Groves
PaymentForPurchasesOfCitrusGroves
29000
CY2022Q4 alco Payments For Proceeds From Deposits On Purchase Of Productive Assets
PaymentsForProceedsFromDepositsOnPurchaseOfProductiveAssets
301000
CY2021Q4 alco Payments For Proceeds From Deposits On Purchase Of Productive Assets
PaymentsForProceedsFromDepositsOnPurchaseOfProductiveAssets
196000
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-496000
CY2021Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4079000
CY2022Q4 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
8902000
CY2021Q4 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
16319000
CY2022Q4 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
23019000
CY2021Q4 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
25696000
CY2022Q4 us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
759000
CY2021Q4 us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
1072000
CY2021Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
170000
CY2022Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3793000
CY2021Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3763000
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9565000
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4712000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-817000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
886000
CY2022Q4 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
1915000
CY2021Q4 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
137000
CY2021Q4 alco Increase Decreasein Prepaid Guaranteed Payments
IncreaseDecreaseinPrepaidGuaranteedPayments
-418000
CY2021Q4 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1576000
CY2022Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-108000
CY2021Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-117000
CY2022Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2822000
CY2021Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6328000
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9665000
CY2021Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9608000
CY2022Q4 alco Payment For Purchases Of Citrus Groves
PaymentForPurchasesOfCitrusGroves
29000
CY2021Q4 alco Payment For Purchases Of Citrus Groves
PaymentForPurchasesOfCitrusGroves
136000
CY2022Q4 alco Payments For Proceeds From Deposits On Purchase Of Productive Assets
PaymentsForProceedsFromDepositsOnPurchaseOfProductiveAssets
301000
CY2022Q4 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
8902000
CY2021Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
170000
CY2022Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3793000
CY2021Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3763000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
865000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
886000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
269000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
69000
CY2022Q4 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities as of the date of the accompanying Financial Statements, the disclosure of contingent assets and liabilities in the Financial Statements and the accompanying Notes, and the reported amounts of revenues and expenses and cash flows during the periods presented. Actual results could differ from those estimates. The Company evaluates estimates on an ongoing basis. The estimates are based on current and expected economic conditions, historical experience, the experience and judgment of the Company’s management and various other specific assumptions that the Company believes to be reasonable.</span></p>
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10588000
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15337000
CY2020 alco Proceeds From Federal Relief Grants
ProceedsFromFederalReliefGrants
4629000
CY2022Q4 alco Proceeds From Federal Relief Grants
ProceedsFromFederalReliefGrants
1300000
CY2022Q1 us-gaap Area Of Land
AreaOfLand
93
CY2022Q1 alco Lease Commencing Date
LeaseCommencingDate
2022-01-01
CY2022Q1 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2025-01-01
CY2022Q1 alco Option Amount To Repurchase
OptionAmountToRepurchase
480000
CY2022Q1 alco Repurchase Price Per Acre
RepurchasePricePerAcre
5161
CY2022Q3 us-gaap Area Of Land
AreaOfLand
85
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
370095000
CY2022Q1 us-gaap Area Of Land
AreaOfLand
93
CY2022Q3 us-gaap Inventory Net
InventoryNet
27682000
CY2022 alco Proceeds From Federal Relief Grants
ProceedsFromFederalReliefGrants
1123000
CY2021 alco Proceeds From Federal Relief Grants
ProceedsFromFederalReliefGrants
4299000
CY2022Q4 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities as of the date of the accompanying Financial Statements, the disclosure of contingent assets and liabilities in the Financial Statements and the accompanying Notes, and the reported amounts of revenues and expenses and cash flows during the periods presented. Actual results could differ from those estimates. The Company evaluates estimates on an ongoing basis. The estimates are based on current and expected economic conditions, historical experience, the experience and judgment of the Company’s management and various other specific assumptions that the Company believes to be reasonable.</span></p>
CY2022Q4 us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
Receivables under contracts, whereby pricing is based on contractual and market prices, are primarily paid at the floor amount and are collected within seven days after the harvest week. Any adjustments to pricing as a result of changes in market prices are generally collected or paid thirty to sixty days after final market pricing is published.
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10588000
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15337000
CY2022Q4 us-gaap Other Inventory
OtherInventory
1011000
CY2022Q4 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities as of the date of the accompanying Financial Statements, the disclosure of contingent assets and liabilities in the Financial Statements and the accompanying Notes, and the reported amounts of revenues and expenses and cash flows during the periods presented. Actual results could differ from those estimates. The Company evaluates estimates on an ongoing basis. The estimates are based on current and expected economic conditions, historical experience, the experience and judgment of the Company’s management and various other specific assumptions that the Company believes to be reasonable.</span></p>
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10588000
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15337000
CY2022Q4 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain prior year amounts have been reclassified in the accompanying Financial Statements for consistent presentation to the current period. These reclassifications had no impact on net income, equity, cash flows or working capital as previously reported.</span></p>
CY2022Q4 us-gaap Agricultural Related Inventory Growing Crops
AgriculturalRelatedInventoryGrowingCrops
27987000
CY2022Q3 us-gaap Agricultural Related Inventory Growing Crops
AgriculturalRelatedInventoryGrowingCrops
26717000
CY2022Q4 us-gaap Other Inventory
OtherInventory
1011000
CY2022Q3 us-gaap Other Inventory
OtherInventory
965000
CY2022Q4 us-gaap Inventory Net
InventoryNet
28998000
CY2022Q3 us-gaap Inventory Net
InventoryNet
27682000
CY2022 alco Proceeds From Federal Relief Grants
ProceedsFromFederalReliefGrants
1123000
CY2021 alco Proceeds From Federal Relief Grants
ProceedsFromFederalReliefGrants
4299000
CY2020 alco Proceeds From Federal Relief Grants
ProceedsFromFederalReliefGrants
4629000
CY2022Q4 alco Proceeds From Federal Relief Grants
ProceedsFromFederalReliefGrants
1300000
CY2022Q1 alco Lease Commencing Date
LeaseCommencingDate
2022-01-01
CY2022Q1 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
Company had granted to Mr. Kiernan an option to purchase the Land from the Company, exercisable only during the one-year period January 1, 2022 through January 1, 2023
CY2022Q1 alco Option Amount To Repurchase
OptionAmountToRepurchase
480000
CY2022Q1 alco Repurchase Price Per Acre
RepurchasePricePerAcre
5161
CY2022Q3 us-gaap Area Of Land
AreaOfLand
85
CY2022Q4 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
25000000
CY2022Q3 alco Debt Instrument Covenant Minimum Debt Coverage Ratio
DebtInstrumentCovenantMinimumDebtCoverageRatio
1.10
CY2022Q3 alco Debt Instrument Covenant Minimum Tangible Net Worth
DebtInstrumentCovenantMinimumTangibleNetWorth
160000000
CY2022 alco Debt Instrument Covenant Percentage Annual Increase
DebtInstrumentCovenantPercentageAnnualIncrease
0.10
CY2022Q4 us-gaap Agricultural Related Inventory Growing Crops
AgriculturalRelatedInventoryGrowingCrops
27987000
CY2022Q3 us-gaap Agricultural Related Inventory Growing Crops
AgriculturalRelatedInventoryGrowingCrops
26717000
CY2022Q4 us-gaap Other Inventory
OtherInventory
1011000
CY2022Q3 us-gaap Other Inventory
OtherInventory
965000
CY2022 alco Proceeds From Federal Relief Grants
ProceedsFromFederalReliefGrants
1123000
CY2022Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P3Y
CY2022Q1 alco Lease Commencing Date
LeaseCommencingDate
2022-01-01
CY2022Q1 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2025-01-01
CY2022Q1 us-gaap Payments For Rent
PaymentsForRent
1860
CY2022Q1 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
Company had granted to Mr. Kiernan an option to purchase the Land from the Company, exercisable only during the one-year period January 1, 2022 through January 1, 2023
CY2022Q1 alco Option Amount To Repurchase
OptionAmountToRepurchase
480000
CY2022Q1 alco Repurchase Price Per Acre
RepurchasePricePerAcre
5161
CY2022Q3 us-gaap Area Of Land
AreaOfLand
85
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
370095000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
372479000
CY2022Q4 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2022 alco Debt Instrument Covenant Minimum Tangible Networth Annual Increase
DebtInstrumentCovenantMinimumTangibleNetworthAnnualIncrease
174462000
CY2022Q4 alco Lineof Credit Facility Covenant Terms Minimum Current Ratio
LineofCreditFacilityCovenantTermsMinimumCurrentRatio
1.50
CY2022Q4 us-gaap Area Of Land
AreaOfLand
85
CY2022Q4 us-gaap Disposal Group Including Discontinued Operation Consideration
DisposalGroupIncludingDiscontinuedOperationConsideration
438900
CY2022Q4 alco Land Sold Price Per Acre
LandSoldPricePerAcre
5161
CY2022Q1 us-gaap Area Of Land
AreaOfLand
93
CY2022Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P3Y
CY2022Q1 alco Lease Commencing Date
LeaseCommencingDate
2022-01-01
CY2022Q1 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2025-01-01
CY2022Q1 us-gaap Payments For Rent
PaymentsForRent
1860
CY2022Q1 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
Company had granted to Mr. Kiernan an option to purchase the Land from the Company, exercisable only during the one-year period January 1, 2022 through January 1, 2023
CY2022Q1 alco Option Amount To Repurchase
OptionAmountToRepurchase
480000
CY2022Q1 alco Repurchase Price Per Acre
RepurchasePricePerAcre
5161
CY2022Q3 us-gaap Area Of Land
AreaOfLand
85
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
372479000
CY2022Q4 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3035000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3035000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
22080000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
3035000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
3035000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
90762000
CY2022Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
1148000
CY2021Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
901000
CY2022Q4 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
281000
CY2021Q4 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
303000
CY2022Q4 us-gaap Interest Costs Incurred
InterestCostsIncurred
1429000
CY2021Q4 us-gaap Interest Costs Incurred
InterestCostsIncurred
1204000
CY2022Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
345000
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
303000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
39000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
120000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3306000
CY2021Q4 us-gaap Area Of Land
AreaOfLand
1638
CY2021Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
6300000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1400000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4900000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
90762000
CY2022Q4 alco Long Term Debt And Line Of Credit
LongTermDebtAndLineOfCredit
124982000
CY2022Q4 alco Debt Instrument Covenant Maximum Capital Expenditure
DebtInstrumentCovenantMaximumCapitalExpenditure
30000000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3035000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3035000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
22080000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
3035000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
3035000
CY2022Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
1148000
CY2021Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
901000
CY2022Q4 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
281000
CY2021Q4 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
303000
CY2022Q4 us-gaap Interest Costs Incurred
InterestCostsIncurred
1429000
CY2021Q4 us-gaap Interest Costs Incurred
InterestCostsIncurred
1204000
CY2022Q4 us-gaap Debt Instrument Interest Rate Increase Decrease
DebtInstrumentInterestRateIncreaseDecrease
0.0385
CY2021Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
25000000
CY2022Q3 alco Debt Instrument Covenant Minimum Tangible Net Worth
DebtInstrumentCovenantMinimumTangibleNetWorth
160000000
CY2022Q4 alco Lineof Credit Facility Covenant Terms Minimum Current Ratio
LineofCreditFacilityCovenantTermsMinimumCurrentRatio
1.50
CY2022Q4 alco Debt Instrument Covenant Maximum Capital Expenditure
DebtInstrumentCovenantMaximumCapitalExpenditure
30000000
CY2022Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0535
CY2022Q3 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
2024000
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
764000
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
777000
CY2022Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1713000
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
380000
CY2022Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
3793000
CY2022Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
853000
CY2022Q3 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
2024000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
951000
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
764000
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
777000
CY2022Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1713000
CY2022Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
345000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
306000
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
303000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
39000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
120000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3306000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9062000
CY2021Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
6300000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1400000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4900000
CY2022 alco Deferred Tax Assets Charitable Contribution Utilized
DeferredTaxAssetsCharitableContributionUtilized
500000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
10131000
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7593000
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7535000
CY2021Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
7000
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7593000
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7542000
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3306000
CY2022 alco Deferred Tax Assets Charitable Contribution Utilized
DeferredTaxAssetsCharitableContributionUtilized
500000
CY2022Q3 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
2024000
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
777000
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
303000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
39000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
120000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9062000
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
580314
CY2021Q4 us-gaap Area Of Land
AreaOfLand
1638
CY2021Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
6300000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1400000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4900000
CY2022 alco Deferred Tax Assets Charitable Contribution Utilized
DeferredTaxAssetsCharitableContributionUtilized
500000
CY2022Q3 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
5800000
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-3150000
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
10131000
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7593000
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.41
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15337000
CY2022Q4 us-gaap Gross Profit
GrossProfit
-3801000
CY2022Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
345000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
306000
CY2022Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
303000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
39000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
120000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3306000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9062000
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
580314
CY2021Q4 us-gaap Area Of Land
AreaOfLand
1638
CY2021Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
6300000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1400000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4900000
CY2022 alco Deferred Tax Assets Charitable Contribution Utilized
DeferredTaxAssetsCharitableContributionUtilized
500000
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7593000
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
14389000
CY2022Q4 us-gaap Gross Profit
GrossProfit
-3801000
CY2021Q4 us-gaap Gross Profit
GrossProfit
1811000
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3950000
CY2021Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3836000
CY2022Q4 us-gaap Assets
Assets
412990000
CY2022Q3 us-gaap Assets
Assets
409255000
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0181
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
0.25
CY2022Q4 us-gaap Purchase Obligation
PurchaseObligation
5403000
CY2021Q4 us-gaap Gross Profit
GrossProfit
1811000
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.34
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.41
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.34
CY2022Q4 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10588000
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15337000
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
14389000
CY2021Q4 us-gaap Cost Of Revenue
CostOfRevenue
13526000
CY2022Q4 us-gaap Gross Profit
GrossProfit
-3801000
CY2021Q4 us-gaap Gross Profit
GrossProfit
1811000
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3950000
CY2021Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3836000
CY2022Q4 us-gaap Assets
Assets
412990000
CY2022Q3 us-gaap Assets
Assets
409255000
CY2022Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
30000
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
829150
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.34
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15337000
CY2022Q4 us-gaap Assets
Assets
412990000
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y8M8D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0181
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
829150
CY2022Q4 us-gaap Assets
Assets
412990000
CY2022Q3 us-gaap Assets
Assets
409255000
CY2022Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
30000
CY2021Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
111000
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y8M8D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0181
CY2022Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
156000
CY2021Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
179000
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
0.25
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
829150
CY2022Q4 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
-146000
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
829150
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
27948000
CY2022Q4 us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
5942
CY2022Q4 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
-146000
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
823208
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
27802000
CY2022Q4 us-gaap Purchase Obligation
PurchaseObligation
5403000
CY2022Q4 us-gaap Purchase Obligation
PurchaseObligation
5403000

Files In Submission

Name View Source Status
0000950170-23-001826-index-headers.html Edgar Link pending
0000950170-23-001826-index.html Edgar Link pending
0000950170-23-001826.txt Edgar Link pending
0000950170-23-001826-xbrl.zip Edgar Link pending
alco-20221231.htm Edgar Link pending
alco-20221231.xsd Edgar Link pending
0000950170-23-001826-index-headers.html Edgar Link pending
0000950170-23-001826-index.html Edgar Link pending
0000950170-23-001826.txt Edgar Link pending
0000950170-23-001826-xbrl.zip Edgar Link pending
alco-20221231.htm Edgar Link pending
alco-20221231.xsd Edgar Link pending
alco-ex31_1.htm Edgar Link pending
alco-ex31_2.htm Edgar Link pending
alco-ex32_1.htm Edgar Link pending
alco-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
alco-20221231_htm.xml Edgar Link completed
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
alco-ex31_1.htm Edgar Link pending
alco-ex31_2.htm Edgar Link pending
alco-ex32_1.htm Edgar Link pending
alco-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
alco-20221231_htm.xml Edgar Link completed
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
alco-20221231_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
alco-20221231_def.xml Edgar Link unprocessable
alco-20221231_lab.xml Edgar Link unprocessable
alco-20221231_pre.xml Edgar Link unprocessable
alco-20221231_def.xml Edgar Link unprocessable
alco-20221231_cal.xml Edgar Link unprocessable
alco-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
alco-20221231_lab.xml Edgar Link unprocessable